This is a summary of the European public assessment report (EPAR) for Actraphane. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Actraphane.
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus.
Therapeutic Area (MeSH)
ATC Code
A10AD01
ATC Item
insulin (human)
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Insulin human | N/A | 人胰岛素 |
EMA Name
Actraphane
Medicine Name
Actraphane
Aliases
N/ANo risk management plan link.
